![]() |
市场调查报告书
商品编码
1954643
视讯喉镜市场规模、占有率、成长及全球产业分析:依产品、类型、最终用户和地区划分的洞察与预测(2026-2034 年)Video Laryngoscope Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025 年全球视讯喉镜市场规模为 5.8111 亿美元,预计将从 2026 年的 6.7899 亿美元增长至 2034 年的 25.8916 亿美元,在预测期(2026-2034 年)内复合年增长率高达 18.21%。
北美将在 2025 年以 47.03% 的市场占有率引领市场,这得益于先进气道管理设备的高普及率、完善的医疗基础设施以及主要市场参与者的强大影响力。
视讯喉镜是一种利用高解析度视讯视觉化气道结构的医疗设备。与视野有限的传统直接喉镜不同,视讯喉镜能够改善视野,提高气管插管(ETT)的成功率,尤其是在处理复杂气道时。
市场趋势
技术进步与一次性器械的应用
市场上的一个显着趋势是,越来越多的先进设备涌现,旨在提高插管过程中的安全性和精准度。製造商正致力于研发高清成像、便携式整合显示系统和符合人体工学的设计,以辅助医护人员进行紧急气道操作。
抛弃式的视讯喉镜日益普及也是一个主要趋势。一次性器械能够降低交叉感染和传播的风险,自新冠疫情爆发以来,其重要性日益凸显。 包括 Intersurgical Ltd. 在内的领先企业正在扩展其产品线,提供一次性使用产品以满足感染控制标准。
企业也采取收购和合作等免疫成长策略,以加强其全球影响力并丰富产品组合。
市场驱动因素
优于直接喉镜
视讯喉镜的广泛应用主要源自于其在临床上优于传统直接喉镜。使用直接喉镜插管失败可能导致严重併发症,包括牙齿损伤、喉痉挛、支气管痉挛、心臟骤停甚至死亡。
研究和临床报告表明,视讯喉镜可提高插管成功率并缩短插管时间。 医疗机构的调查显示,随着视讯设备的广泛应用,困难插管和插管失败的发生率显着下降。
此外,全球肥胖率的上升和急诊入院人数的增加推动了对先进气道管理工具的需求。肥胖患者的困难气道管理病例更多,这进一步强化了对可视化插管设备的需求。
限制因子
新兴市场成本高且普及率有限
儘管成长潜力巨大,但设备的高昂成本是一个主要的限制因素。可重复使用的视讯喉镜价格在 1,000 美元到 8,000 美元之间,远高于传统的一次性喉镜。
在新兴市场,有限的保险覆盖范围和预算限制往往阻碍了设备的普及。 维护成本和低成本替代品的存在也对市场扩张构成挑战。
依产品分类
市场区隔将可重复使用型和抛弃式视觉喉镜分为两类。
预计到2026年,可重复使用型喉镜将占88.48%的市场占有率,这主要得益于其技术优势、在紧急情况下易于操作以及与一次性镜片的兼容性。 然而,由于人们对感染控制的日益关注,一次性喉镜市场预计将显着增长。
依型别分类
依类型划分,市场分为推车式和整合式显示式两种。
预计到2026年,推车式喉镜将占63.07%的市场占有率,这主要得益于其较高的产品供应量和价格优势。 然而,由于整合显示型号的便携性、紧凑设计以及在紧急情况下和到达医院前现场使用的便利性,预计其增长速度将更快。
依最终使用者划分
市场细分为医院、耳鼻喉科诊所及其他(急诊医疗机构、急诊服务等)。
预计到2026年,医院细分市场将占89.83%的主导占有率,这主要得益于需要麻醉和插管的手术数量众多。 手术和急救转运数量的增加持续推动着该领域的成长。
北美
北美将继续保持其最大的区域市场地位,预计2025年市场规模将达到2.7327亿美元。在先进的医疗基础设施和医疗器材普及的推动下,美国市场预计在2026年达到3.1957亿美元。
欧洲
由于肥胖率上升和医疗体系的进步,欧洲市场预计将实现显着的复合年增长率。
亚太地区
由于医疗基础设施的不断完善和微创医疗意识的提高,预计亚太地区市场将实现快速成长。 侵入性气道管理。
由于认知度低和经济挑战,拉丁美洲以及中东和非洲目前的市占率较小。
北美凭藉其先进的医疗保健系统和对技术的早期应用,在 2025 年将以 47.03% 的市场占有率领先。 推动成长的关键因素包括:困难气道管理病例数量的增加、肥胖症盛行率的上升、技术进步以及对微创插管手术日益增长的偏好。
儘管高昂的成本和有限的保险覆盖范围仍然是新兴市场的挑战,但在持续的技术创新、外科手术数量的增加以及全球医疗基础设施的扩张的推动下,预计强劲的市场增长将持续到2034年。
The global video laryngoscope market was valued at USD 581.11 million in 2025 and is projected to grow from USD 678.99 million in 2026 to USD 2,589.16 million by 2034, registering a strong CAGR of 18.21% during the forecast period (2026-2034).
North America dominated the market with a 47.03% share in 2025, supported by high adoption of advanced airway management devices, developed healthcare infrastructure, and strong presence of leading market players.
A video laryngoscope is a medical device that enables visualization of airway structures using a high-resolution video system. Unlike traditional direct laryngoscopes, which offer a limited view of the larynx, video laryngoscopes provide enhanced visualization, improving the success rate of endotracheal tube (ETT) placement, especially in difficult airway cases.
Market Trends
Technological Advancements and Disposable Device Adoption
One of the prominent trends in the market is the introduction of technologically advanced devices designed to improve safety and precision during intubation. Manufacturers are focusing on high-definition imaging, portable integrated display systems, and ergonomic designs to assist healthcare professionals during emergency airway procedures.
The increasing availability of fully disposable video laryngoscopes is another major trend. Disposable devices reduce cross-contamination risks and infection transmission, which became especially important after the COVID-19 pandemic. Companies such as Intersurgical Ltd. and other key players are expanding their portfolios with single-use options to meet infection control standards.
Inorganic growth strategies such as acquisitions and partnerships are also being adopted to strengthen global presence and product portfolios.
Market Driving Factors
Superiority Over Direct Laryngoscopy
The growing adoption of video laryngoscopes is largely driven by their clinical advantages over traditional direct laryngoscopy devices. Failed intubation attempts using direct laryngoscopes can lead to severe complications such as dental injury, laryngeal spasms, bronchospasm, cardiac arrest, and even fatalities.
Studies and clinical publications have demonstrated higher success rates and shorter intubation times with video laryngoscopes. According to surveys conducted by medical associations, difficult and failed intubation rates have declined significantly with the increasing use of video-based devices.
Additionally, the global rise in obesity prevalence and increasing emergency hospital admissions are contributing to the demand for advanced airway management tools. Difficult airway cases are more common among obese patients, further strengthening the need for visualization-based intubation devices.
Restraining Factors
High Cost and Limited Adoption in Emerging Markets
Despite strong growth potential, high device costs remain a key restraint. Reusable video laryngoscopes can cost between USD 1,000 and USD 8,000, significantly higher than traditional single-use laryngoscopes.
Emerging economies often face limited reimbursement coverage and budget constraints, restricting widespread adoption. Maintenance costs and availability of lower-cost alternatives also present challenges for market expansion.
By Product
The market is segmented into reusable and single-use video laryngoscopes.
The reusable segment dominated with an 88.48% share in 2026, owing to technical superiority, ease of operation during emergency procedures, and compatibility with disposable blades. However, the single-use segment is expected to grow at a significant rate due to increasing focus on infection control.
By Type
Based on type, the market is divided into cart-based models and integrated display models.
The cart-based segment held a dominant share of 63.07% in 2026, primarily due to strong product availability and higher pricing. However, integrated display models are projected to grow at a faster pace due to portability, compact design, and convenience in emergency and pre-hospital settings.
By End-Users
The market is categorized into hospitals, ENT clinics, and others (pre-hospital & EMS).
The hospitals segment held a dominant share of 89.83% in 2026, driven by a high number of surgeries requiring anesthesia and intubation. Increased surgical procedures and emergency admissions continue to support segment growth.
North America
North America accounted for USD 273.27 million in 2025 and remained the largest regional market. The U.S. market is projected to reach USD 319.57 million in 2026, supported by advanced healthcare infrastructure and strong device adoption.
Europe
Europe is expected to witness significant CAGR growth due to increasing obesity rates and advanced healthcare systems.
Asia Pacific
Asia Pacific is projected to grow rapidly due to expanding healthcare infrastructure and rising awareness of minimally invasive airway management.
Latin America and Middle East & Africa currently hold smaller shares due to limited awareness and affordability challenges.
Competitive Landscape
The market is consolidated, led by major players such as:
Strong product portfolios, global distribution networks, and innovation-driven strategies contribute to market leadership.
Conclusion
The global video laryngoscope market is set for robust expansion from USD 581.11 million in 2025 to USD 678.99 million in 2026, reaching USD 2,589.16 million by 2034, at a CAGR of 18.21%.
North America led the market in 2025 with a 47.03% share, driven by advanced healthcare systems and early technology adoption. Growth is primarily fueled by increasing difficult airway cases, rising obesity prevalence, technological advancements, and growing preference for minimally invasive intubation procedures.
Although high costs and limited reimbursement in emerging markets present challenges, continuous innovation, increasing surgical procedures, and expanding healthcare infrastructure worldwide are expected to sustain strong market growth through 2034.
Segmentation
By Product
By Type
By End Users
By Geography